1. D. J. Cutler. Theory of the mean absorption time, an adjunct to conventional bioavailability studies.J. Pharm. Pharmac. 30:476–478 (1978).
2. K. Yamaoka, T. Nakagawa, and T. Uno. Statistical moments in pharmacokinetics.J. Pharmacokin. Biopharm. 6:547–557 (1978).
3. S. Riegelman and P. Collier. The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption time.J. Pharmacokin. Biopharm. 8:509–534 (1980).
4. H. M. von Hattingberg and D. Brockmeier. Standardisierung von Rechenmodellen zur Priifung der Bioverfügbarkeit von Arzenimitteln. In N. Rietbrock, B. Schnieders (eds.),Bioverfügbarkeit von Arzenimitteln. Gustav Fischer, Stuttgart, 1979, pp. 191–209.
5. H. M. von Hattingberg and D. Brockmeier. A concept for the assessment of bioavailability in complex systems in terms of amounts and rates. In G. Bozler and J. M. van Rossum (eds.),Pharmacokinetics During Drug Development: Data Analysis and Evaluation Techniques. Gustav Fischer Verlag, New York, 1982, pp. 315–323.